Acme United AI Stock Analysis
Want to see ACU full AI Analyst Report?
Acme United (ACU) AI Stock Analysis
Acme United
(NYSE MKT:ACU)
ACU scores well overall primarily due to strong technical momentum and a notably positive earnings call with constructive Q4/2027 outlook. Financials are steady but held back by softer recent free-cash-flow growth and higher debt versus recent periods. Valuation is a modest headwind given the ~23.8 P/E and ~0.91% dividend yield.
Acme United (ACU) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $263.97M
- Dividend Yield
- 0.96%
- Average Volume (3M)
- 40.66K
- Price to Earnings (P/E)
- 22.6
- Beta (1Y)
- 0.31
- Revenue Growth
- 13.13%
- EPS Growth
- 11.31%
- Country
- US
- Employees
- 649
- Sector
- Consumer Defensive
- Sector Strength
- 62
- Industry
- Household & Personal Products
Acme United Business Overview & Revenue Model
Company Description
Acme United Corporation is a global supplier specializing in first aid, safety, cutting, sharpening, and measuring tools. Its products cater to a diverse clientele across educational institutions, households, corporate offices, hardware stores, sport...
How the Company Makes Money
Acme United makes money primarily by selling branded physical products to retailers, distributors, and other business customers. Revenue is generated from (1) the sale of first aid and safety products—such as first aid kits and related safety supplie...
Acme United Earnings Call Summary
The call was strongly positive overall. Acme reported 18% quarterly sales growth, 80% net income growth, 74% earnings-per-share growth, improved gross margins, strong U.S. and international performance, positive My Medic contribution, expanding Spill Magic capacity, strong cash generation, and a favorable near-term outlook. The main challenges were higher SG&A, DMT closure costs, increased net debt and inventory, elevated freight and inflation, supply chain risks, and potential consumer pressure, but management described active measures to address these issues and continued growth opportunities for 2027.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
Management said the fourth quarter is expected to be seasonally strong in both sales and earnings and that it is projecting a solid fourth quarter of 2026; savings from closing the DMT plant are expected to be over $1 million annually, beginning in January 2027, and the latest SmartCompliance First Aid kit is planned to begin shipping in January 2027. The company has already booked new business for 2027, expects normal promotions next year if conditions remain unchanged, and said that, if consumer conditions stay the same, it is looking at a very good 2027 with the Westcott business as well as First Aid. Management also said it expects sometime in the next 12 months there'll probably be another deal, noting that every year it winds up doing at least one, and that it personally thinks the company will bring inventory into cash during 2027.
Acme United Financial Statement Overview
Summary
Steady TTM revenue growth (~4.2%) with stable profitability (TTM gross margin ~41.7%, net margin ~5.1%) supports a solid base. Offsetting this, cash flow is softer (TTM FCF growth down ~10.9% and operating cash flow coverage vs. obligations below 1.0), and leverage has risen versus recent years despite a still-manageable debt-to-equity (~0.38).
Income Statement
72PositiveBalance Sheet
64PositiveCash Flow
58Neutral| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 220.55M | 196.54M | 194.49M | 191.50M | 193.96M | 182.09M |
| Gross Profit | 91.92M | 77.41M | 76.35M | 72.21M | 63.56M | 64.80M |
| EBITDA | 21.37M | 21.15M | 20.44M | 30.90M | 10.64M | 20.15M |
| Net Income | 11.35M | 10.19M | 10.02M | 17.79M | 3.03M | 13.66M |
Balance Sheet | ||||||
| Total Assets | 207.86M | 171.00M | 162.17M | 149.24M | 164.38M | 144.44M |
| Cash, Cash Equivalents and Short-Term Investments | 7.94M | 3.60M | 6.40M | 4.80M | 6.10M | 4.84M |
| Total Debt | 46.49M | 28.26M | 32.84M | 25.51M | 63.42M | 47.48M |
| Total Liabilities | 82.99M | 53.39M | 55.19M | 51.34M | 85.35M | 67.36M |
| Stockholders Equity | 124.87M | 117.61M | 106.98M | 97.90M | 79.03M | 77.08M |
Cash Flow | ||||||
| Free Cash Flow | 13.80M | 7.58M | 4.83M | 23.92M | -1.71M | -1.23M |
| Operating Cash Flow | 19.07M | 18.23M | 11.98M | 28.90M | 2.89M | 5.14M |
| Investing Cash Flow | -21.50M | -12.30M | -12.94M | 7.43M | -14.23M | -6.37M |
| Financing Cash Flow | 5.26M | -8.88M | 2.00M | -38.44M | 14.28M | 2.04M |
Acme United Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For ACU, the sentiment is Neutral. The current price of 66.53 is below the 20-day moving average (MA) of 67.37, above the 50-day MA of 64.24, and above the 200-day MA of 51.56, indicating a neutral trend. The MACD of 1.52 indicates Positive momentum. The RSI at 49.35 is Neutral, neither overbought nor oversold. The STOCH value of 33.42 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for ACU.
Acme United Risk Analysis
Acme United disclosed 34 risk factors in its most recent earnings report. Acme United reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
2 New RisksAcme United Peers Comparison
Overall Rating
ACU72Outperform
SLSN57Neutral
SKIN54Neutral
EPC51Neutral
NUS41Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 72Outperform | $263.97M | 22.59 | 9.45% | 0.96% | 13.13% | 11.31% | |
| Sector * | 62Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |
| 57Neutral | $113.04M | 38.48 | 18.04% | ― | -1.95% | 122.62% | |
| 54Neutral | $98.46M | -5.32 | -32.09% | ― | -4.41% | -51.42% | |
| 51Neutral | $1.31B | -24.92 | -3.53% | 2.11% | -10.21% | -310.40% | |
| 41Neutral | $191.30M | -0.81 | -34.83% | 6.11% | -15.27% | -318.35% |
* Consumer Defensive Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| ACU | Acme United Corporation. | 66.53 | 31.35 | 89.09% | |
| NUS | Nu Skin Enterprises | 3.93 | -5.27 | -57.27% | |
| EPC | Edgewell Personal Care Co | 28.38 | 11.98 | 73.08% | |
| SLSN | Solesence, Inc | 1.60 | -0.27 | -14.44% | |
| SKIN | Beauty Health Company | 15.05 | -11.15 | -42.56% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 11, 2026
